Zentalis Pharmaceuticals (ZNTL) Payables (2022 - 2025)
Historic Payables for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $7.0 million.
- Zentalis Pharmaceuticals' Payables fell 1427.7% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 1427.7%. This contributed to the annual value of $7.4 million for FY2024, which is 5016.75% down from last year.
- Per Zentalis Pharmaceuticals' latest filing, its Payables stood at $7.0 million for Q3 2025, which was down 1427.7% from $3.7 million recorded in Q2 2025.
- Zentalis Pharmaceuticals' Payables' 5-year high stood at $20.4 million during Q2 2024, with a 5-year trough of $3.7 million in Q2 2025.
- In the last 4 years, Zentalis Pharmaceuticals' Payables had a median value of $11.2 million in 2022 and averaged $11.0 million.
- Per our database at Business Quant, Zentalis Pharmaceuticals' Payables skyrocketed by 6611.13% in 2024 and then tumbled by 8180.53% in 2025.
- Quarter analysis of 4 years shows Zentalis Pharmaceuticals' Payables stood at $11.2 million in 2022, then surged by 32.71% to $14.9 million in 2023, then plummeted by 50.17% to $7.4 million in 2024, then dropped by 5.47% to $7.0 million in 2025.
- Its last three reported values are $7.0 million in Q3 2025, $3.7 million for Q2 2025, and $7.8 million during Q1 2025.